Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Q3 2023 Sanofi SA Earnings Call Transcript

Oct 27, 2023 / 12:30PM GMT
Release Date Price: $43.16 (-18.21%)
Eva Schaefer;Jansen
Sanofi - Head of IR

Good morning, good afternoon, and good evening to everyone. Thank you for joining us to review Sanofi's third quarter 2023 results, followed by a Q&A session. As usual, you can find the slides to this call on the Investors page of our website at sanofi.com.

Moving to Slide 3, I would like to remind you that information presented in this call contains forward-looking statements that involves known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our (foreign language) for a description of these risk factors.

With this, please advance to Slide 4. Our speakers on the call today are Paul Hudson, Chief Executive Officer; Jean-Baptiste de Chatillon, Chief Financial Officer; Houman Ashrafian, Global Head of R&D; and Julie Van Ongevalle, Global Business Unit Head, Consumer Healthcare. The Global Business Unit heads, Brian Foard, Thomas Triomphe and Olivier Charmeil, will join for Q&A, to which you have two

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot